April 7, 2024
You are here:  Home  >  Health Care & Life Science  >  Current Article

Arcutis planning $152 million IPO


A relative newcomer to the Conejo Valley biotech landscape plans to follow up the region’s largest venture capital deal of 2019 with a $152 million public debut in 2020. Coming off a year of mega-deals in the biopharma space, Arcutis Biotherapeutics detailed plans to take its clinical-stage topical plaque psoriasis product public in filings with…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.